Acasti Pharma (NQ: ACST )
2.450
+0.050
(+2.08%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Acasti Pharma
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/08/penny-stocks-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/image46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: Acasti Pharma Q4 Earnings
June 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/18/image47_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/vaccine-4892059.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](/next-assets/images/schema-image-default.png)
Acasti Pharma's Earnings Outlook
February 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3588.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/05/image20.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/10/wall-street-bull.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_108.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image47.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image40.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image_3.jpg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21347.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
November 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30794.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21251.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/06/21/biotech8.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19176.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3586.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/18/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.